Aldeyra Therapeutics (ALDX) PT Raised to $13 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Justin Kim raised the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $13.00 (from $11.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
